Replies to post #451960 on NorthWest Biotherapeutics Inc (NWBO)

[Red_Right_Hand]

Bigfoot, from May 12, 2021 PR:

https://nwbio.com/uk-manufacturing-facility-phase-iii-trial-updates-from-northwest-biotherapeutics-otcqb-nwbo/

"The process outlined in the Company’s October 5, 2020 announcement relating to the Phase III trial of DCVax-L is continuing to move forward. The process includes review and analysis of the raw data by independent statisticians and experts, and preparation of summaries of the Trial results for review by the Company, the Principal Investigator, the Steering Committee of the Trial, the Scientific Advisory Board, and a panel of independent brain cancer experts in preparation for public announcement and scientific publication."

[Bob_LobLaw]

they stated their goal was to release Top line data with a "prestigious" journal that will lend credibility to the data. that is all we have gotten since Oct 2020. We have no idea if we are in peer review stage, whether the article is being written or if we have even secured a journal. apparently it is okay to keep investors in the dark 18 months post data lock.

1 year ago today they did tell us that we would get data "in coming months" So in march of 2021 they either felt we were close enough to use those words or were flat out lying. the delay to that point was due to covid. What is the reason now? to be honest I dont want to see another BS PR because I and the rest of the market have no faith in anything they say. this management team has been lying for years. cancer patients and investors need to hear 1 of 2 things. an announcement that the board is replacing leadership (never happen this board is in LP's pocket) or top line data. anything else is useless.